Intra-Cellular Therapies Ratios and Metrics

Market cap in millions GBP. Fiscal year is April - March.

Millions GBP. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Aug '25 Aug 5, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	2016 - 2020
Market Capitalization	69	84	67	44	21	3	Upgrade
Market Cap Growth	-3.32%	25.66%	52.43%	106.49%	556.25%	-72.82%	Upgrade
Enterprise Value	51	82	64	41	21	3	Upgrade
Last Close Price	0.00	0.00	0.00	0.00	0.00	0.00	Upgrade
PE Ratio	2.66	3.09	-	-	-	-	Upgrade
PB Ratio	1.28	1.46	4.49	3.63	1.68	0.40	Upgrade
P/TBV Ratio	1.34	1.52	185.16	67.65	5.78	-	Upgrade
Quick Ratio	205.83	141.81	0.70	2.59	6.87	0.08	Upgrade
Current Ratio	205.83	142.38	1.34	2.59	6.87	0.08	Upgrade
Return on Equity (ROE)	76.38%	75.19%	-10.83%	-7.31%	-6.03%	-7.94%	Upgrade
Return on Assets (ROA)	-6.02%	-5.71%	-6.48%	-4.29%	-3.36%	-4.60%	Upgrade
Return on Capital (ROIC)	-6.41%	-5.78%	-6.77%	-4.47%	-3.57%	-4.96%	Upgrade
Earnings Yield	38.01%	32.37%	-2.19%	-2.06%	-2.94%	-19.45%	Upgrade
FCF Yield	-2.43%	-3.02%	-0.99%	-1.75%	-2.71%	-16.31%	Upgrade
Buyback Yield / Dilution	-20.86%	-13.01%	-6.35%	-37.12%	-31.21%	-18.04%	Upgrade

Updated Dec 23, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.